Table S1 from ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
Amir Arabzade(Baylor College of Medicine), Stephen C. Mack(Hospital for Sick Children), Yanhua Zhao(City University of Hong Kong), Minerva Solis(Baylor College of Medicine), Yuen San Chan(The University of Texas MD Anderson Cancer Center), Peter R. Wang(Rice University), Brian Golbourn(University of Pittsburgh), Kelsey C. Bertrand(University of Toronto), Baoli Hu(University of Pittsburgh), Susan M. Blaney(Center for Cancer and Blood Disorders), Kathleen Kong(Baylor College of Medicine), Charles Y. Lin(Baylor College of Medicine), Luz A. De León(Children's Cancer Center), Claudia L. Kleinman(Jewish General Hospital), Dana Tlais(Baylor College of Medicine), H. Courtney Hodges(The University of Texas MD Anderson Cancer Center), Kristen L. Karlin(Baylor College of Medicine), Thomas F. Westbrook(Baylor College of Medicine), Alisha Kardian(Baylor College of Medicine), Stefan M. Pfister(Heidelberg University), Madeline Ngo(Rice University), Srinidhi Varadharajan(Baylor College of Medicine), Sarah G. Injac(Baylor College of Medicine), Austin J. Stuckert(Baylor College of Medicine), Irtisha Singh(J. Craig Venter Institute), Sameer Agnihotri(University of Pittsburgh), Bryan Rivas(Baylor College of Medicine), Ann-Catherine J. Stanton(Children's Hospital of Pittsburgh), Benjamin Deneen(Baylor College of Medicine), Robert Kupp(Cancer Research UK Cambridge Center), Felix Sahm(German Cancer Research Center), Daisuke Kawauchi(German Cancer Research Center), Selin Jessa(Simon Fraser University), Nada Jabado(McGill University), Donald W. Parsons, Murali Chintagumpala(St Nicholas Hospital), Hsiao‐Chi Chen(Baylor College of Medicine), Richard J. Gilbertson(University of Cambridge), Kristian W. Pajtler(German Cancer Research Center)
Cited by 0
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Challenges to curing primary brain tumours
|Nature Reviews Clinical Oncology|2019|965
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867